Skip to main content
. 2019 Apr 30;92(18):e2070–e2080. doi: 10.1212/WNL.0000000000007232

Table 2.

Baseline characteristics of Investigation of Naproxen Treatment Effects in Pre-symptomatic Alzheimer's Disease (INTREPAD) participants

graphic file with name NEUROLOGY2018911255TT2.jpg